Institutional Ownership
Cytomx Therapeutics Inc
CUSIP 23284F105COMCTMXQ1 2026
13D / 13G Filings
64
Schedule 13D/13G on record
Beneficial Filers
25
Distinct reporting persons
Largest Stake
14.6%
Max % of class reported
Institutional Holders
172
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
64 filings · latest Mar 4, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 4, 2026 | Kynam Capital Management, LP | 13G | 5.3% | 8.97M | SEC |
| 2 | Feb 17, 2026 | Tang Capital Management, LLC | 13G/A | — | — | SEC |
| 3 | Feb 17, 2026 | Orbimed Advisors LLC | 13G/A | 2.1% | 3.53M | SEC |
| 4 | Feb 5, 2026 | Fmr LLC | 13G/A | 14.6% | 24.69M | SEC |
| 5 | Nov 14, 2025 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 9.4% | 15.56M | SEC |
| 6 | Nov 14, 2025 | Seven Fleet Master Fund LP | 13G/A | 0.0% | 48.9K | SEC |
| 7 | Nov 14, 2025 | Point72 Asset Management, L.P. | 13G/A | 2.5% | 4.07M | SEC |
| 8 | Nov 7, 2025 | Fmr LLC | 13G/A | 12.4% | 20.52M | SEC |
| 9 | Nov 5, 2025 | Fmr LLC | 13G/A | 9.3% | 15.40M | SEC |
| 10 | Aug 21, 2025 | Perceptive Advisors LLC | 13G | 5.9% | 9.68M | SEC |
54 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Cytomx Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 31.96M | $150.19M |
| 2 | Kynam Capital Management, LP | 15.01M | $70.56M |
| 3 | Bank Of America Corp /De/ | 10.20M | $47.95M |
| 4 | Perceptive Advisors LLC | 10.10M | $47.46M |
| 5 | Venrock Adviser, LLC | 9.98M | $46.92M |
| 6 | Point72 Asset Management, L.P. | 7.88M | $37.01M |
| 7 | State Street Corp | 5.66M | $26.62M |
| 8 | Citadel Advisors LLC | 5.41M | $25.41M |
| 9 | Blackrock, Inc. | 5.23M | $24.57M |
| 10 | Baker Bros. Advisors LP | 4.98M | $23.39M |